Çѱ¹ÀÇÇÐ³í¹® µ¥ÀÌÅͺ£À̽º
Á¦¸ñ 2¿ù ÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 

 

ÃֽŠÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®

 

2¿ù ÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®




 

Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ 2¿ù¿¡ ÀÇ°úÇÐºÐ¾ß ±¹³»Àú³Î°ú ±¹Á¦ Àú³ÎÀ» ÅëÇØ ¹ßÇ¥ÇÑ ³í¹® ÃÑ 3,173ÆíÀ» ºÐ¾ßº°·Î ºÐ·ùÇÏ¿© Å°¿öµå ºÐ¼®ÇÏ¿´´Ù. 2¿ù¿¡ ¹ßÇ¥µÈ ÀÇ°úÇÐ ¿¬±¸µ¿Çâ Å°¿öµå ºÐ¼®¿¡¼­ COVID-19, Vaccination, Complication, Risk, Neoplasm µîÀ» Áß½ÉÀ¸·Î ÇÏ´Â Å°¿öµå´Â Áö¼ÓÀûÀ¸·Î ÀÇ°úÇкоßÀÇ ÇÙ½É ÅäÇÈÀ¸·Î ³ªÅ¸³µÀ¸¸ç, ÁÖ¿ä ¿¬±¸µ¿Çâ  ³×Æ®¿öÅ©¸¦ Çü¼ºÇÏ¿´´Ù. ƯÈ÷ COVID-19¿Í °ü·ÃµÈ °³³äÀÎ vaccination, complication, risk, mortality ¹× global Health µîÀÇ °³³äÀº ÀÓ»óÀÇÇÐ, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ, °£È£Çко߿¡¼­ ÁÖ¿ä °ü½É ¿¬±¸ÁÖÁ¦·Î ³ªÅ¸³µ´Ù.  ÀÇ°úÇבּ¸µ¿Ç⠺м®¿¡ »ç¿ëµÈ ³í¹®µ¥ÀÌÅÍ´Â 2022³â 2¿ù¿¡ ±¹³»¿Í ±¹¿Ü Àú³ÎÀ» ÅëÇØ  ¹ßÇ¥µÈ ³í¹® Áß¿¡¼­ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿Í Æà¸Þµå(PubMed) µ¥ÀÌÅͺ£À̽º¿¡ À妽ºµÈ ³í¹®ÀڷḦ ÃßÃâÇÏ¿© ºÐ¼®ÇÏ¿´´Ù. 

 

ÀÇ°úÇÐ ºÐ¾ßº° ¹ßÇ¥ÇöȲÀ» »ìÆ캸¸é ÀÓ»óÀÇÇÐ 1,586Æí, ±âÃÊÀÇÇÐ 1,098Æí, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ 333Æí, °£È£ÇÐ 77Æí, Ä¡ÀÇÇÐ 79ÆíÀ¸·Î ³ªÅ¸³µ´Ù. ±¹³» Àú³ÎÀ» ÅëÇØ 755ÆíÀÌ °ÔÀçµÇ¾úÀ¸¸ç, ±¹¿Ü Àú³ÎÀ» ÅëÇÑ ³í¹®Àº 2,148ÆíÀ¸·Î ±¹Á¦Àú³ÎÀ» ÅëÇÑ ³í¹®¹ßÇ¥°¡ 27.2% ³ôÀº ºñÁßÀ» Â÷ÁöÇÏ¿´´Ù. ¿¬±¸¹ßÇ¥ ½ÇÀûÀ» Àü¿ù 1¿ù¿¡ ¹ßÇ¥µÈ 2,944Æí°ú ºñ±³Çϸé 229Æí °¨¼ÒÇÑ Ãß¼¼¸¦ ³ªÅ¸³»¾ú´Ù. ÀÇ°úÇÐ Àüü ±¹³»Àú³Î ¹× ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ Å°¿öµå¸¦ ÅëÇÕ ºÐ¼®ÇÑ ÈÄ¿¡ ºÐ¾ßº°·Î ±âÃÊÀÇÇÐ, ÀÓ»óÀÇÇÐ, ¿¹¹æÀÇÇÐ, Ä¡ÀÇÇÐ, °£È£ÇÐ ºÐ¾ß·Î ¼¼ºÎ ºÐ·ùÇÏ¿© ÃֽŠÇÙ½É ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© Ŭ¶ó¿ìµå ºÐ¼® ¹× ÇÙ½É Å°¿öµå¸¦ ºÐ¼® ÃßÃâÇÏ¿´´Ù.  ºÐ¾ßº° ÇÙ½É ¿¬±¸µ¿Çâ Å°¿öµå Ŭ¶ó¿ìµå´Â ¾Æ·¡¿Í °°´Ù.



 

Ç¥ 1.  2¿ù ÀÇ°úÇÐ ÅëÇÕ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå(N=3,173)  

Å°¿öµå ¼øÀ§

±¹³» ÀÇ°úÇÐ ¿¬±¸µ¿Çâ 

±¹¿Ü ÀÇ°úÇÐ ¿¬±¸µ¿Çâ

ÀÇ°úÇÐ ¿¬±¸µ¿Çâ 

1

Risk

Risk

Risk

2

COVID-19

Genes

Genes

3

Vaccination

Neoplasms

Neoplasms

4

Women

Attention

Women

5

Stroke

Women

Attention

6

Complication

Humans

Role

7

Genes

Role

COVID-19

8

General Surgery

General Surgery

Humans

9

Role

Sensitivity And Specificity

General Surgery

10

Neoplasms

Survival Rate

Complication







 

 

                        ±×¸² 1.   ÀÇ°úÇÐ ÅëÇÕ  2¿ù ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå






 

                 ±×¸² 2. ±¹³» Àú³Î ¹ßÇ¥ 2¿ù ÀÇ°úÇÐ ¿¬±¸µ¿Çâ Å°¿öµå ³×Æ®¿öÅ© ºÐ¼® 








 

 

±×¸² 3. ±¹¿Ü Àú³Î ¹ßÇ¥ 2¿ù ÀÇ°úÇÐ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®




 

Ç¥  2. ÀÇ°úÇР 2¿ù ÅäÇÈ ³×Æ®¿öÅ© ¸ðµ¨¸µ   

Topic1

Topic2

Topic3

Topic4

Topic5

In Vitro Techniques

Complication

Neoplasms

Sensitivity & Specificity

Pediatrics

Metabolism

Mortality

Recurrence

Vaccination

Women

DNA

Risk

Liver

COVID-19

Exercise

Anti-Bacterial Agents

Death

Survival Rate

Water

Depression

Efficiency

Population

General Surgery

Soil

Pain

Genes

Women

Prognosis

Attention

Adult

Economics

Stroke

Drug

F-18 Fdg Pet

Older Adults

Attention

Adult

Neoplasm Metastasis

Environment

Behavior

Humans

Diabetes

Drug Therapy

Technology

Brain

Role

General Surgery

Fibrosis

Efficiency

Risk

 




 

±×¸²  4.   ÀÇ°úÇР Å°¿öµå ÃßÃâ  ¸ðµ¨¸µ ³×Æ®¿öÅ©  ºÐ¼®

 

ºÐ¾ßº° ÀÇ°úÇÐ ³í¹® ¹ßÇ¥ÇöȲÀº ÀÓ»óÀÇÇÐ 1,586Æí, ±âÃÊÀÇÇÐ 1,098Æí, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ 333Æí, Ä¡ÀÇÇÐ 79Æí, °£È£ÇÐ 77Æí ¼øÀ¸·Î ¹ßÇ¥µÇ¾î ÀÓ»óÀÇÇÐºÐ¾ß ³í¹®¹ßÇ¥°¡ ÀÇ°úÇко߿¡¼­ 50%¸¦ Â÷ÁöÇÏ¿© °¡Àå ¸¹Àº ³í¹®½ÇÀûÀ» ³ªÅ¸³»¾ú´Ù. ±¹³»¹ßÇ¥¿Í ±¹¿Ü¹ßÇ¥¸¦ ºñ±³ÇØ º¼ ¶§ ±¹³» ³í¹®¹ßÇ¥´Â 755Æí ±¹¿Ü¹ßÇ¥´Â 2,418ÆíÀ¸·Î ±¹³»¹ßÇ¥´Â ÀüüÀÇ 31.2%¿¡ ºÒ°úÇÏ¿´´Ù. ÀÌ´Â ±¹³» ÀÇ°úÇÐºÐ¾ß ¿¬±¸ÀÚµéÀÌ ±¹¿Ü ÇмúÁö¸¦ ÅëÇØ ¿¬±¸½ÇÀû ¹ßÇ¥¸¦ ¼±È£ÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù. 











 

      ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø






 

* º» ³»¿ëÀº MedRIC (www.medric.or.kr)ÀÇ ¿¬±¸µ¿Çâ¿¡¼­ ¼­ºñ½ºµÇ´Â ³»¿ëÀÔ´Ï´Ù.



 


2022-03-25 ¿ÀÈÄ 4:41:25, Á¶È¸¼ö : 640